Causes of Death Among Medical ICU Patients With Pneumonia Due to COVID-19 in a Safety-Net Hospital
- PMID: 37465700
- PMCID: PMC10351933
- DOI: 10.1097/CCE.0000000000000947
Causes of Death Among Medical ICU Patients With Pneumonia Due to COVID-19 in a Safety-Net Hospital
Abstract
We sought to identify the primary causes of death of adult patients admitted to the medical ICU with symptomatic COVID-19 who ultimately suffered in-hospital mortality over the span of three major waves of COVID-19: Wild-type, alpha/epsilon, and delta.
Design: Retrospective single-center cohort study from March 2020 to December 2021.
Setting: One medical ICU in a 600-bed Tertiary Care Hospital in Los Angeles, CA.
Patients: Adult (n = 306) ICU patients admitted with symptomatic COVID-19 who suffered in-hospital mortality.
Interventions: None.
Main results: Of the 306 patients with COVID-19 who died in the hospital, 86.3% were Hispanic/Latino. The leading cause of death was respiratory failure, occurring in 57.8% of patients. There was no significant change in the rate of pulmonary deaths across the three waves of COVID-19 in our study period. The mean time from symptom onset to admission was 6.5 days, with an average hospital length of stay of 18 days. This did not differ between pulmonary and other causes of death. Sepsis was the second most common cause of death at 23.9% with a significant decrease from the wild-type wave to the delta wave. Among patients with sepsis as the cause of death, 22% (n = 16) were associated with fungemia. There was no significant association between steroid administration and cause of death. Lastly, the alpha/epsilon wave from December 2020 to May 2021 had the highest mortality rate when compared with wild-type or delta waves.
Conclusions: We found the primary cause of death in ICU patients with COVID-19 was acute respiratory failure, without significant changes over the span of three waves of COVID-19. This finding contrasts with reported causes of death for patients with non-COVID-19 acute respiratory distress syndrome, in which respiratory failure is an uncommon cause of death. In addition, we identified a subset of patients (5%) who died primarily due to fungemia, providing an area for further investigation.
Keywords: COVID-19; death; fungemia; respiratory distress syndrome; respiratory failure.
Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Conflict of interest statement
Supported by educational grants from the National Center for Advancing Translational Science of the U.S. National Institutes of Health, grants UL1TR001855 and UL1TR000130. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by an educational grant from the Los Angeles County Medical Center Committee for Interns and Residents.
Figures



Similar articles
-
Comparison of ICU Mortality Rates Among Critically Ill COVID-19 Pneumonia Patients Across the First and Second Waves: A Single-Center Retrospective Analysis.Cureus. 2025 Jan 17;17(1):e77587. doi: 10.7759/cureus.77587. eCollection 2025 Jan. Cureus. 2025. PMID: 39958031 Free PMC article.
-
Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City.Cureus. 2023 Feb 12;15(2):e34894. doi: 10.7759/cureus.34894. eCollection 2023 Feb. Cureus. 2023. PMID: 36925973 Free PMC article.
-
Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis.Swiss Med Wkly. 2021 Aug 10;151:w20569. doi: 10.4414/smw.2021.20569. eCollection 2021 Aug 2. Swiss Med Wkly. 2021. PMID: 34375985
-
An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature.Sci Rep. 2023 May 13;13(1):7804. doi: 10.1038/s41598-023-34613-x. Sci Rep. 2023. PMID: 37179397 Free PMC article. Review.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
Cited by
-
Associated organs and system with COVID-19 death with information of organ support: a multicenter observational study.BMC Infect Dis. 2023 Nov 20;23(1):814. doi: 10.1186/s12879-023-08817-5. BMC Infect Dis. 2023. PMID: 37986049 Free PMC article.
References
-
- World Health Organization: WHO coronavirus (COVID-19) dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data, 2022. Available at: https://covid19.who.int/. Accessed December 5, 2022
-
- Kim L, Garg S, O’Halloran A, et al. : Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) [Internet]. Clin Infect Dis 2021; 72:e206–e214 - PMC - PubMed
-
- Wiersinga WJ, Rhodes A, Cheng AC, et al. : Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 2020; 324:782–793 - PubMed
-
- Variants - Coronavirus COVID-19 response. Calif Dep Public Heal Genomic Surveill Data 2022. Available at: https://covid19.ca.gov/variants/. Accessed November 22, 2022
LinkOut - more resources
Full Text Sources